Literature DB >> 36087131

Endoscopic transnasal surgery in optic pathway gliomas located in the chiasma-hypothalamic region: case series of ten patients in a single-center experience and endoscopic literature review.

Eren Yilmaz1, Atakan Emengen2, Ecem Cemre Ceylan1, Burak Cabuk1, Ihsan Anik1, Savas Ceylan3.   

Abstract

OBJECTIVE: Optic pathway gliomas (OPGs) constitute approximately 3-5% of childhood intracranial tumors. In this study, the authors presented their experience of using the endoscopic endonasal approach to treat patients with OPG located in the chiasma-hypothalamic region and aimed to use the infrachiasmatic corridor in the endoscopic endonasal approach as an alternative to the transcranial approach in the surgical necessity of OPGs.
METHODS: We retrospectively analyzed the data of ten patients diagnosed with OPG histopathologically among 3757 cases who underwent endoscopic endonasal surgery between August 1997 and March 2021 at Kocaeli University Faculty of Medicine Pituitary Research Center and Department of Neurosurgery. Mean follow-up period 48.5 months. During the postoperative follow-up period, 3 of these 10 patients underwent reoperation due to tumor recurrence. Combined (endoscopic endonasal approach + transcranial approach) approach was applied to 2 patients in the same session. Surgical and clinical outcomes were evaluated in detail.
RESULTS: Ten patients with a mean patient age of 20.6 ± 11.4 were included in this study. The most common complaint was visual impairment. After surgery, improvement in visual impairment was observed in five patients. No increase in postoperative visual impairment was observed in any of the patients. Postoperative panhypopituitarism was not observed in any of the patients. STR resection was performed in 5 patients and NTR resection in 5 patients. No additional treatment was required during follow-up in 4 of 5 patients who underwent NTR. A total of 6 patients received postoperative radiotherapy treatment.
CONCLUSIONS: In gliomas located in the chiasma-hypothalamic region, appropriate patient selection and endoscopic endonasal surgical treatment may contribute to the elimination of symptoms due to the mass effect of the tumor. It may also contribute to keeping the disease under control with targeted adjuvant therapies by clarifying the pathological diagnosis of the lesion.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Chiasm; Endoscopic; Optic glioma; Vision

Year:  2022        PMID: 36087131     DOI: 10.1007/s00381-022-05665-7

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.532


  37 in total

1.  Long-term clinical and visual outcomes after surgical resection of pediatric pilocytic/pilomyxoid optic pathway gliomas.

Authors:  Eveline Teresa Hidalgo; Svetlana Kvint; Cordelia Orillac; Emily North; Yosef Dastagirzada; Jamie Chiapei Chang; Gifty Addae; Tara S Jennings; Matija Snuderl; Jeffrey H Wisoff
Journal:  J Neurosurg Pediatr       Date:  2019-05-17       Impact factor: 2.375

Review 2.  Optic pathway gliomas: a review.

Authors:  Mandy J Binning; James K Liu; John R W Kestle; Douglas L Brockmeyer; Marion L Walker
Journal:  Neurosurg Focus       Date:  2007       Impact factor: 4.047

3.  Radiological classification of optic pathway gliomas: experience of a modified functional classification system.

Authors:  T Taylor; T Jaspan; G Milano; R Gregson; T Parker; T Ritzmann; C Benson; D Walker
Journal:  Br J Radiol       Date:  2008-10       Impact factor: 3.039

4.  Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up.

Authors:  A J Janss; R Grundy; A Cnaan; P J Savino; R J Packer; E H Zackai; J W Goldwein; L N Sutton; J Radcliffe; P T Molloy
Journal:  Cancer       Date:  1995-02-15       Impact factor: 6.860

5.  A population-based study of the incidence and survival rates in patients with pilocytic astrocytoma.

Authors:  Christoph Burkhard; Pier-Luigi Di Patre; Danielle Schüler; Georges Schüler; M Gazi Yaşargil; Yasuhiro Yonekawa; Urs M Lütolf; Paul Kleihues; Hiroko Ohgaki
Journal:  J Neurosurg       Date:  2003-06       Impact factor: 5.115

6.  Endoscopic transnasal resection of optic pathway pilocytic astrocytoma.

Authors:  Sarah Bin Abdulqader; Ziyad Al-Ajlan; Abdulrahman Albakr; Wisam Issawi; Mohammed Al-Bar; Pablo F Recinos; Saad Alsaleh; Abdulrazag Ajlan
Journal:  Childs Nerv Syst       Date:  2018-10-18       Impact factor: 1.475

7.  The role of surgery in optic pathway/hypothalamic gliomas in children.

Authors:  John Goodden; Barry Pizer; Benedetta Pettorini; Dawn Williams; Jo Blair; Mohammed Didi; Nicky Thorp; Conor Mallucci
Journal:  J Neurosurg Pediatr       Date:  2013-10-18       Impact factor: 2.375

8.  Clinico-pathological features of pilomyxoid astrocytoma of the optic pathway.

Authors:  Kanako Chikai; Akiko Ohnishi; Tsutomu Kato; Jun Ikeda; Yutaka Sawamura; Yoshinobu Iwasaki; Tomoo Itoh; Hirofumi Sawa; Kazuo Nagashima
Journal:  Acta Neuropathol       Date:  2004-05-27       Impact factor: 17.088

Review 9.  Neurosurgical experience of managing optic pathway gliomas.

Authors:  Ciaran Scott Hill; Mehdi Khan; Kim Phipps; Katherine Green; Darren Hargrave; Kristian Aquilina
Journal:  Childs Nerv Syst       Date:  2021-02-03       Impact factor: 1.475

Review 10.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.